The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global 3D Bioprinting Market Research Report 2024
Synopsis
3D Bioprinting is the utilization of 3D printing and 3D printing–like techniques to combine cells, growth factors, and biomaterials to fabricate biomedical parts that maximally imitate natural tissue characteristics.
The global 3D Bioprinting market was valued at US$ 9658.2 million in 2023 and is anticipated to reach US$ 33240 million by 2030, witnessing a CAGR of 18.8% during the forecast period 2024-2030.
The global 3D bioprinting market is segmented into four broad categories, namely, microextrusion, inkjet, laser-assisted, and magnetic 3D bioprinting.The global inkjet based 3D bioprinting market is anticipated to reach 1423.5 million by 2025, at a CAGR of 21.3% from 2017 to 2025.Magnetic 3D bioprinting is expected to show the fastest growth during the forecast period.
This report aims to provide a comprehensive presentation of the global market for 3D Bioprinting, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding 3D Bioprinting.
Report Scope
The 3D Bioprinting market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global 3D Bioprinting market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the 3D Bioprinting companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Organovo Holdings Inc
EnvisionTEC GmbH
Nano3D Biosciences, Inc
Cyfuse Biomedical K.K
Advanced Solutions, Inc
Aspect Biosystems Ltd
3Dynamic Systems Ltd
regenHU
Cellink
Regenovo Biotechnology Co., Ltd
Poietis
GeSiM
Exone
Stratasys
Advanced BioMatrix
Ricoh Company Ltd
Segment by Type
Magnetic 3D Bioprinting
Laser-assisted Bioprinting
Inkjet 3D Bioprinting
Microextrusion 3D Bioprinting
Segment by Application
Clinical Applications
Research Applications
Drug and Medical Research
Regenerative Medicine
3D Cell Culture
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of 3D Bioprinting companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
3D Bioprinting is the utilization of 3D printing and 3D printing–like techniques to combine cells, growth factors, and biomaterials to fabricate biomedical parts that maximally imitate natural tissue characteristics.
The global 3D Bioprinting market was valued at US$ 9658.2 million in 2023 and is anticipated to reach US$ 33240 million by 2030, witnessing a CAGR of 18.8% during the forecast period 2024-2030.
The global 3D bioprinting market is segmented into four broad categories, namely, microextrusion, inkjet, laser-assisted, and magnetic 3D bioprinting.The global inkjet based 3D bioprinting market is anticipated to reach 1423.5 million by 2025, at a CAGR of 21.3% from 2017 to 2025.Magnetic 3D bioprinting is expected to show the fastest growth during the forecast period.
This report aims to provide a comprehensive presentation of the global market for 3D Bioprinting, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding 3D Bioprinting.
Report Scope
The 3D Bioprinting market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global 3D Bioprinting market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the 3D Bioprinting companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Organovo Holdings Inc
EnvisionTEC GmbH
Nano3D Biosciences, Inc
Cyfuse Biomedical K.K
Advanced Solutions, Inc
Aspect Biosystems Ltd
3Dynamic Systems Ltd
regenHU
Cellink
Regenovo Biotechnology Co., Ltd
Poietis
GeSiM
Exone
Stratasys
Advanced BioMatrix
Ricoh Company Ltd
Segment by Type
Magnetic 3D Bioprinting
Laser-assisted Bioprinting
Inkjet 3D Bioprinting
Microextrusion 3D Bioprinting
Segment by Application
Clinical Applications
Research Applications
Drug and Medical Research
Regenerative Medicine
3D Cell Culture
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of 3D Bioprinting companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global 3D Bioprinting Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Magnetic 3D Bioprinting
1.2.3 Laser-assisted Bioprinting
1.2.4 Inkjet 3D Bioprinting
1.2.5 Microextrusion 3D Bioprinting
1.3 Market by Application
1.3.1 Global 3D Bioprinting Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinical Applications
1.3.3 Research Applications
1.3.4 Drug and Medical Research
1.3.5 Regenerative Medicine
1.3.6 3D Cell Culture
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global 3D Bioprinting Market Perspective (2019-2030)
2.2 3D Bioprinting Growth Trends by Region
2.2.1 Global 3D Bioprinting Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 3D Bioprinting Historic Market Size by Region (2019-2024)
2.2.3 3D Bioprinting Forecasted Market Size by Region (2025-2030)
2.3 3D Bioprinting Market Dynamics
2.3.1 3D Bioprinting Industry Trends
2.3.2 3D Bioprinting Market Drivers
2.3.3 3D Bioprinting Market Challenges
2.3.4 3D Bioprinting Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top 3D Bioprinting Players by Revenue
3.1.1 Global Top 3D Bioprinting Players by Revenue (2019-2024)
3.1.2 Global 3D Bioprinting Revenue Market Share by Players (2019-2024)
3.2 Global 3D Bioprinting Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by 3D Bioprinting Revenue
3.4 Global 3D Bioprinting Market Concentration Ratio
3.4.1 Global 3D Bioprinting Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by 3D Bioprinting Revenue in 2023
3.5 3D Bioprinting Key Players Head office and Area Served
3.6 Key Players 3D Bioprinting Product Solution and Service
3.7 Date of Enter into 3D Bioprinting Market
3.8 Mergers & Acquisitions, Expansion Plans
4 3D Bioprinting Breakdown Data by Type
4.1 Global 3D Bioprinting Historic Market Size by Type (2019-2024)
4.2 Global 3D Bioprinting Forecasted Market Size by Type (2025-2030)
5 3D Bioprinting Breakdown Data by Application
5.1 Global 3D Bioprinting Historic Market Size by Application (2019-2024)
5.2 Global 3D Bioprinting Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America 3D Bioprinting Market Size (2019-2030)
6.2 North America 3D Bioprinting Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America 3D Bioprinting Market Size by Country (2019-2024)
6.4 North America 3D Bioprinting Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe 3D Bioprinting Market Size (2019-2030)
7.2 Europe 3D Bioprinting Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe 3D Bioprinting Market Size by Country (2019-2024)
7.4 Europe 3D Bioprinting Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific 3D Bioprinting Market Size (2019-2030)
8.2 Asia-Pacific 3D Bioprinting Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific 3D Bioprinting Market Size by Region (2019-2024)
8.4 Asia-Pacific 3D Bioprinting Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America 3D Bioprinting Market Size (2019-2030)
9.2 Latin America 3D Bioprinting Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America 3D Bioprinting Market Size by Country (2019-2024)
9.4 Latin America 3D Bioprinting Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa 3D Bioprinting Market Size (2019-2030)
10.2 Middle East & Africa 3D Bioprinting Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa 3D Bioprinting Market Size by Country (2019-2024)
10.4 Middle East & Africa 3D Bioprinting Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Organovo Holdings Inc
11.1.1 Organovo Holdings Inc Company Detail
11.1.2 Organovo Holdings Inc Business Overview
11.1.3 Organovo Holdings Inc 3D Bioprinting Introduction
11.1.4 Organovo Holdings Inc Revenue in 3D Bioprinting Business (2019-2024)
11.1.5 Organovo Holdings Inc Recent Development
11.2 EnvisionTEC GmbH
11.2.1 EnvisionTEC GmbH Company Detail
11.2.2 EnvisionTEC GmbH Business Overview
11.2.3 EnvisionTEC GmbH 3D Bioprinting Introduction
11.2.4 EnvisionTEC GmbH Revenue in 3D Bioprinting Business (2019-2024)
11.2.5 EnvisionTEC GmbH Recent Development
11.3 Nano3D Biosciences, Inc
11.3.1 Nano3D Biosciences, Inc Company Detail
11.3.2 Nano3D Biosciences, Inc Business Overview
11.3.3 Nano3D Biosciences, Inc 3D Bioprinting Introduction
11.3.4 Nano3D Biosciences, Inc Revenue in 3D Bioprinting Business (2019-2024)
11.3.5 Nano3D Biosciences, Inc Recent Development
11.4 Cyfuse Biomedical K.K
11.4.1 Cyfuse Biomedical K.K Company Detail
11.4.2 Cyfuse Biomedical K.K Business Overview
11.4.3 Cyfuse Biomedical K.K 3D Bioprinting Introduction
11.4.4 Cyfuse Biomedical K.K Revenue in 3D Bioprinting Business (2019-2024)
11.4.5 Cyfuse Biomedical K.K Recent Development
11.5 Advanced Solutions, Inc
11.5.1 Advanced Solutions, Inc Company Detail
11.5.2 Advanced Solutions, Inc Business Overview
11.5.3 Advanced Solutions, Inc 3D Bioprinting Introduction
11.5.4 Advanced Solutions, Inc Revenue in 3D Bioprinting Business (2019-2024)
11.5.5 Advanced Solutions, Inc Recent Development
11.6 Aspect Biosystems Ltd
11.6.1 Aspect Biosystems Ltd Company Detail
11.6.2 Aspect Biosystems Ltd Business Overview
11.6.3 Aspect Biosystems Ltd 3D Bioprinting Introduction
11.6.4 Aspect Biosystems Ltd Revenue in 3D Bioprinting Business (2019-2024)
11.6.5 Aspect Biosystems Ltd Recent Development
11.7 3Dynamic Systems Ltd
11.7.1 3Dynamic Systems Ltd Company Detail
11.7.2 3Dynamic Systems Ltd Business Overview
11.7.3 3Dynamic Systems Ltd 3D Bioprinting Introduction
11.7.4 3Dynamic Systems Ltd Revenue in 3D Bioprinting Business (2019-2024)
11.7.5 3Dynamic Systems Ltd Recent Development
11.8 regenHU
11.8.1 regenHU Company Detail
11.8.2 regenHU Business Overview
11.8.3 regenHU 3D Bioprinting Introduction
11.8.4 regenHU Revenue in 3D Bioprinting Business (2019-2024)
11.8.5 regenHU Recent Development
11.9 Cellink
11.9.1 Cellink Company Detail
11.9.2 Cellink Business Overview
11.9.3 Cellink 3D Bioprinting Introduction
11.9.4 Cellink Revenue in 3D Bioprinting Business (2019-2024)
11.9.5 Cellink Recent Development
11.10 Regenovo Biotechnology Co., Ltd
11.10.1 Regenovo Biotechnology Co., Ltd Company Detail
11.10.2 Regenovo Biotechnology Co., Ltd Business Overview
11.10.3 Regenovo Biotechnology Co., Ltd 3D Bioprinting Introduction
11.10.4 Regenovo Biotechnology Co., Ltd Revenue in 3D Bioprinting Business (2019-2024)
11.10.5 Regenovo Biotechnology Co., Ltd Recent Development
11.11 Poietis
11.11.1 Poietis Company Detail
11.11.2 Poietis Business Overview
11.11.3 Poietis 3D Bioprinting Introduction
11.11.4 Poietis Revenue in 3D Bioprinting Business (2019-2024)
11.11.5 Poietis Recent Development
11.12 GeSiM
11.12.1 GeSiM Company Detail
11.12.2 GeSiM Business Overview
11.12.3 GeSiM 3D Bioprinting Introduction
11.12.4 GeSiM Revenue in 3D Bioprinting Business (2019-2024)
11.12.5 GeSiM Recent Development
11.13 Exone
11.13.1 Exone Company Detail
11.13.2 Exone Business Overview
11.13.3 Exone 3D Bioprinting Introduction
11.13.4 Exone Revenue in 3D Bioprinting Business (2019-2024)
11.13.5 Exone Recent Development
11.14 Stratasys
11.14.1 Stratasys Company Detail
11.14.2 Stratasys Business Overview
11.14.3 Stratasys 3D Bioprinting Introduction
11.14.4 Stratasys Revenue in 3D Bioprinting Business (2019-2024)
11.14.5 Stratasys Recent Development
11.15 Advanced BioMatrix
11.15.1 Advanced BioMatrix Company Detail
11.15.2 Advanced BioMatrix Business Overview
11.15.3 Advanced BioMatrix 3D Bioprinting Introduction
11.15.4 Advanced BioMatrix Revenue in 3D Bioprinting Business (2019-2024)
11.15.5 Advanced BioMatrix Recent Development
11.16 Ricoh Company Ltd
11.16.1 Ricoh Company Ltd Company Detail
11.16.2 Ricoh Company Ltd Business Overview
11.16.3 Ricoh Company Ltd 3D Bioprinting Introduction
11.16.4 Ricoh Company Ltd Revenue in 3D Bioprinting Business (2019-2024)
11.16.5 Ricoh Company Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
